Cargando…
Dopaminergic neuron injury in Parkinson’s disease is mitigated by interfering lncRNA SNHG14 expression to regulate the miR-133b/ α-synuclein pathway
This study explored the influence of long non-coding RNA (lncRNA) SNHG14 on α-synuclein (α-syn) expression and Parkinson’s disease (PD) pathogenesis. Firstly, we found that the expression level of SNHG14 was elevated in brain tissues of PD mice. In MN9D cells, the rotenone treatment (1μmol/L) enhanc...
Autores principales: | Zhang, Li-Min, Wang, Meng-Han, Yang, He-Cheng, Tian, Tian, Sun, Gui-Fang, Ji, Yang-Fei, Hu, Wen-Tao, Liu, Xi, Wang, Jian-Ping, Lu, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874444/ https://www.ncbi.nlm.nih.gov/pubmed/31683259 http://dx.doi.org/10.18632/aging.102330 |
Ejemplares similares
-
Commentary: LncRNA-T199678 Mitigates α-Synuclein-Induced Dopaminergic Neuron Injury via miR-101-3p
por: Wang, Youcui, et al.
Publicado: (2021) -
LncRNA-T199678 Mitigates α-Synuclein-Induced Dopaminergic Neuron Injury via miR-101-3p
por: Bu, Lu-Lu, et al.
Publicado: (2020) -
LncRNA SNHG14 regulates the DDP-resistance of non-small cell lung cancer cell through miR-133a/HOXB13 pathway
por: Xu, Li, et al.
Publicado: (2020) -
Exosome-mediated transfer of lncRNA-SNHG14 promotes trastuzumab chemoresistance in breast cancer
por: Dong, Huaying, et al.
Publicado: (2018) -
Exosome-mediated transfer of lncRNA-SNHG14 promotes trastuzumab chemoresistance in breast cancer
por: Dong, Huaying, et al.
Publicado: (2022)